Table: Sapporo Clinical Lab -2020/21 group forecast
May 7 (Reuters) -
Sapporo Clinical Laboratory Co Ltd
CONSOLIDATED EARNINGS ESTIMATES
(in billions of yen unless specified)
Full Year to Full Year to
Mar 31, 2021 Mar 31, 2021
LATEST PREVIOUS
FORECAST FORECAST
Sales 17.50 17.23
Operating 1.14 620 mln
Recurring 1.19 635 mln
Net 793 mln 407 mln
EPS 231.85 yen 119.03 yen
NOTE - Sapporo Clinical Laboratory Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=9776.T
Recent news on Sapporo Clinical Laboratory
See all newsTable: Sapporo Clinical Lab - 9-MTH group results
Table: Sapporo Clinical Lab - 6-MTH group results
Brief: Sapporo Clinical Laboratory Inc - To Retire Treasury Shares Worth 26% Of Outstanding Stock On Feb 17
Table: Sapporo Clinical Lab -Q1 group results
Table: Sapporo Clinical Lab -2024/25 parent results